Cargando…
Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer’s Disease and Mild Cognitive Impairment: A Pilot Study
The lack of sensitive and specific biomarkers for the early detection of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) is a major hurdle to improving patient management. A targeted, quantitative metabolomics approach using both (1)H NMR and mass spectrometry was employed to investigat...
Autores principales: | Yilmaz, Ali, Ugur, Zafer, Bisgin, Halil, Akyol, Sumeyya, Bahado-Singh, Ray, Wilson, George, Imam, Khaled, Maddens, Michael E., Graham, Stewart F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569858/ https://www.ncbi.nlm.nih.gov/pubmed/32878308 http://dx.doi.org/10.3390/metabo10090357 |
Ejemplares similares
-
Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson’s Disease: A Pilot Study
por: Yilmaz, Ali, et al.
Publicado: (2020) -
The Biochemical Profile of Post-Mortem Brain from People Who Suffered from Epilepsy Reveals Novel Insights into the Etiopathogenesis of the Disease
por: Lalwani, Ashna M., et al.
Publicado: (2020) -
Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
por: Akyol, Sumeyya, et al.
Publicado: (2021) -
Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer’s disease
por: Bahado-Singh, Ray O., et al.
Publicado: (2021) -
Artificial Intelligence and Circulating Cell-Free DNA Methylation Profiling: Mechanism and Detection of Alzheimer’s Disease
por: Bahado-Singh, Ray O., et al.
Publicado: (2022)